Mouse Cytochrome P450 (Cyp3a11): Predominant Expression in Liver and Capacity to Activate Aflatoxin B1
- 1 April 1997
- journal article
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 340 (2) , 215-218
- https://doi.org/10.1006/abbi.1997.9900
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 22 references indexed in Scilit:
- P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclaturePharmacogenetics, 1996
- Molecular cloning and functional expression of a mouse cytochrome P-450 (Cyp3a-13): examination of Cyp3a-13 enzyme to activate aflatoxin B1 (AFB1)Biochimica et Biophysica Acta (BBA) - General Subjects, 1994
- The Human Hepatic Cytochromes P450 Involved in Drug MetabolismCritical Reviews in Toxicology, 1992
- Bioactivation of aflatoxin B1 by human liver microsomes: Role of cytochrome P450 IIIA enzymesToxicology and Applied Pharmacology, 1991
- Developmental expression of rabbit cytochrome P450 CYP1 A1, CYP1 A2 and CYP3 A6 genesEuropean Journal of Biochemistry, 1991
- Catalytic activities of human liver cytochrome P-450 IIIA4 expressed in Saccharomyces cerevisiaeBiochemistry, 1990
- Variables Influencing DNA-Binding in Mouse LiverPublished by Springer Nature ,1987
- Metabolic basis of the species difference to aflatoxin B1 induced hepatotoxicityBiochemical and Biophysical Research Communications, 1983
- Differences in aflatoxin B1-susceptibility of rat and mouse are correlated with the capability in vitro to inactivate aflatoxin B1- epoxideCarcinogenesis: Integrative Cancer Research, 1981
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979